Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
Don't Forget the Feet
National Report - A new study has found a significant discrepancy in survival rates between two groups of patients with melanoma. The five-year survival rate of patients with malignant melanoma on the leg, knee, or thigh was 84 percent, while the survival rate for patients with melanoma of the foot or ankle was 52 percent, said Susan M. Walsh, D.P.M., one of the authors of the study.
Related Videos
Related Content
